According to Galmed Pharmaceuticals 's latest financial reports the company's total assets are $17.63 M. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $16.56 M | -54.76% |
2021-12-31 | $36.6 M | -30.12% |
2020-12-31 | $52.38 M | -32.1% |
2019-12-31 | $77.13 M | -14.86% |
2018-12-31 | $90.6 M | 361.23% |
2017-12-31 | $19.64 M | 19.41% |
2016-12-31 | $16.45 M | -32.2% |
2015-12-31 | $24.26 M | -26.31% |
2014-12-31 | $32.92 M | 19734.34% |
2013-12-31 | $0.16 M | -78.22% |
2012-12-31 | $0.76 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Evoke Pharma
EVOK | $7.06 M | -59.92% | ๐บ๐ธ USA |
Endo International
ENDPQ | $5.13 B | 29,026.26% | ๐ฎ๐ช Ireland |
Aerie Pharmaceuticals AERI | $0.37 B | 2,029.44% | ๐บ๐ธ USA |
Catalent CTLT | $9.98 B | 56,527.74% | ๐บ๐ธ USA |